Financials

News Ideas Discussions Technicals Seasonals

SNPHY fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Santen Pharmaceutical Co., Ltd.

Total assets of SNPHY for Q1 24 is 2.70 B USD, 6.25% less than the previous Q4 23. And total liabilities decreased by 7.44% in Q1 24 to 797.08 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—